NCT02211144View on ClinicalTrials.gov

Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered Twice Daily Orally to Healthy Human Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

November 30, 2002

Conditions
Healthy
Interventions
DRUG

BIBR 796 BS

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY